Scarica l'app Stockscreener
94.78
0.00%
0.00
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$94.78
Aprire:
$94.75
Volume 24 ore:
1.57M
Relative Volume:
0.71
Capitalizzazione di mercato:
$18.35B
Reddito:
$8.23B
Utile/perdita netta:
$705.10M
Rapporto P/E:
26.72
EPS:
3.5467
Flusso di cassa netto:
$1.12B
1 W Prestazione:
+1.78%
1M Prestazione:
+2.44%
6M Prestazione:
-7.01%
1 anno Prestazione:
-3.21%
Intervallo 1D:
$94.59
$96.56
Intervallo di 1 settimana:
$92.24
$97.81
Portata 52W:
$84.59
$108.29
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Nome
Zimmer Biomet Holdings Inc
Settore
Industria
Telefono
(574) 267-6131
Indirizzo
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
94.78 | 18.35B | 8.23B | 705.10M | 1.12B | 3.5467 |
ABT
Abbott Laboratories
|
96.81 | 165.90B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
343.32 | 129.59B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.19 | 109.96B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.23 | 94.25B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.99 | 45.58B | 6.07B | 1.06B | 1.34B | 1.8063 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-23 | Downgrade | BTIG Research | Buy → Neutral |
| 2026-02-20 | Iniziato | William Blair | Mkt Perform |
| 2026-01-09 | Downgrade | Goldman | Neutral → Sell |
| 2026-01-06 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2026-01-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-12-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-11-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-09-18 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-07-15 | Aggiornamento | Roth Capital | Neutral → Buy |
| 2024-12-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Iniziato | Wolfe Research | Peer Perform |
| 2024-07-01 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-21 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Iniziato | ROTH MKM | Neutral |
| 2023-08-28 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-05-03 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Aggiornamento | Jefferies | Underperform → Hold |
| 2023-03-29 | Iniziato | UBS | Sell |
| 2023-03-10 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Underweight |
| 2022-10-12 | Iniziato | Jefferies | Underperform |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-04-01 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-02 | Ripresa | BofA Securities | Underperform |
| 2022-03-02 | Downgrade | Loop Capital | Buy → Hold |
| 2022-02-08 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Reiterato | Citigroup | Buy |
| 2022-02-08 | Reiterato | Deutsche Bank | Hold |
| 2022-02-08 | Reiterato | JMP Securities | Mkt Outperform |
| 2022-02-08 | Reiterato | JP Morgan | Neutral |
| 2022-02-08 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Reiterato | Stifel | Buy |
| 2022-02-08 | Reiterato | Truist | Buy |
| 2022-02-08 | Reiterato | UBS | Neutral |
| 2022-02-08 | Reiterato | Wells Fargo | Underweight |
| 2022-02-02 | Downgrade | UBS | Buy → Neutral |
| 2022-01-19 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Downgrade | Mizuho | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Downgrade | Needham | Strong Buy → Buy |
| 2021-12-07 | Iniziato | Loop Capital | Buy |
| 2021-11-23 | Downgrade | Argus | Buy → Hold |
| 2021-09-14 | Ripresa | Raymond James | Mkt Perform |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-09 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Reiterato | Needham | Strong Buy |
| 2020-10-20 | Iniziato | Northland Capital | Market Perform |
| 2020-09-11 | Iniziato | Wolfe Research | Outperform |
| 2020-08-05 | Reiterato | Needham | Strong Buy |
| 2020-04-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-09 | Downgrade | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Reiterato | Needham | Strong Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-07 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2019-09-18 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Aggiornamento | Argus | Hold → Buy |
| 2019-07-30 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Aggiornamento | Needham | Buy → Strong Buy |
Mostra tutto
Zimmer Biomet Holdings Inc Borsa (ZBH) Ultime notizie
Zimmer Biomet Receives FDA Clearance for Expanded Reverse Shoulder Systems - Orthopedics This Week
Leerink Sees Limited Near-Term Upside for Zimmer Biomet Holdings, Inc. (ZBH) Ahead of 2027 Catalysts - Insider Monkey
Thomasville National Bank Sells 102,815 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Short Interest Up 24.8% in March - MarketBeat
Ambulatory Surgical Equipment Market to Reach USD 14.58 Billion, Rising at 7.85% by 2035 - GlobeNewswire Inc.
Border to Coast Pensions Partnership Ltd Acquires 35,159 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
ZBH Technical Analysis | Trend, Signals & Chart Patterns | ZIMMER BIOMET HOLDINGS INC (NYSE:ZBH) - ChartMill
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Zimmer Biomet Shareholder Vote Puts Board Leadership And Valuation In Focus - simplywall.st
Zimmer Biomet stock (US98956P1021): Is its knee implant dominance strong enough to unlock new upside - AD HOC NEWS
Leerink Partners initiates coverage of Zimmer Biomet Holdings (ZBH) with market perform recommendation - MSN
Zimmer Biomet stock (US98956P1021): Is supply chain resilience now the real test for medtech growth? - AD HOC NEWS
Leerink Partners Begins Coverage on Zimmer Biomet (NYSE:ZBH) - MarketBeat
Leerink initiates Zimmer Biomet stock coverage with Market Perform By Investing.com - Investing.com India
Leerink initiates Zimmer Biomet stock coverage with Market Perform - Investing.com
The Bull Case For Zimmer Biomet (ZBH) Could Change Following First Outpatient Robotic Shoulder Replacement - Sahm
Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer - Florida Hospital News and Healthcare Report
Wall Street Zen Upgrades Zimmer Biomet (NYSE:ZBH) to Buy - MarketBeat
Zimmer Biomet’s Quarterly Earnings Preview: What You Need to Know - Yahoo Finance
SNDL vs. Zimmer Biomet: A Financial Comparison - National Today
Douglas Lane & Associates LLC Raises Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Comerica Bank Lifts Stake in Zimmer Biomet Holdings, Inc. (ZBH) Amid Robotics Drive - MSN
Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2026 Financial Results - BioSpace
Zimmer Biomet (ZBH) Valuation Check After Mixed Returns And Robotics Growth Plans - Sahm
Zimmer Biomet (ZBH) Valuation Check After New Technology Leadership And Robotic Shoulder Surgery Milestones - Yahoo Finance
Zimmer Biomet Holdings, Inc. (ZBH) stock price, news, quote and history - Yahoo Finance UK
Zimmer Biomet Holdings Inc. stock rises Wednesday, still underperforms market - MarketWatch
Goldman Sachs Adjusts Zimmer Biomet Price Target to $89 From $88, Maintains Sell Rating - Moomoo
Oak Thistle LLC Grows Stake in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Sivik Global Healthcare LLC's Zimmer Biomet Holdings Inc(ZBH) Holding History - GuruFocus
Zimmer Biomet Holdings, Inc. Appoints Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer, Effective April 14, 2026 - marketscreener.com
Zimmer Biomet (ZBH) Appoints New Leader for Science and Technolo - GuruFocus
Zimmer hires chief science, technology and medical affairs officer - Yahoo Finance
Hospital for Special Surgery surgeon takes top tech role at Zimmer Biomet - Stock Titan
Fitch Affirms Zimmer Biomet at 'BBB'; Outlook Stable - marketscreener.com
Zimmer Biomet Holdings, Inc. (ZBH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Zimmer Biomet (NYSE: ZBH) exec vests 6,626 RSUs; 1,677 shares withheld - Stock Titan
Q3 2025 Zimmer Biomet Holdings Inc Earnings Call Transcript - GuruFocus
Zimmer Biomet (NYSE: ZBH) director adds 182 phantom stock units to deferred holdings - Stock Titan
Zimmer Biomet (NYSE: ZBH) director awarded new phantom stock units - Stock Titan
Zimmer Biomet (ZBH) director Louis Shapiro granted 154 Phantom Stock Units - Stock Titan
Zimmer Biomet (NYSE: ZBH) director receives new phantom stock unit grant - Stock Titan
Zimmer Biomet (NYSE: ZBH) director adds phantom stock units award - Stock Titan
Zimmer Biomet (NYSE: ZBH) director receives 154 Phantom Stock Units in deferred award - Stock Titan
Zimmer Biomet (NYSE: ZBH) director adds phantom stock units in deferred award - stocktitan.net
Zimmer Biomet (ZBH) director receives phantom stock unit award as deferred pay - Stock Titan
Matrix Asset Advisors Inc. NY Sells 90,174 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Receives Shareholder Proposal from John Chevedden - marketscreener.com
John Chevedden Submits Shareholder Proposal to Zimmer Biomet - marketscreener.com
Zimmer Biomet Holdings Inc Azioni (ZBH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):